Health and Healthcare

Amgen : AMGN

All Amgen Articles

707 Articles

Chris Lange | Sep 9, 2019 at 3:55 PM EDT

Amgen’s Lung Cancer Study Needs to Take a Breather

Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data…

Jon C. Ogg | Aug 29, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, Bank of America, Box, Chico’s FAS, Microsoft, Netflix, NXP, StoneCo, Tiffany and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Amgen, Bank of America, Box, Chico's FAS, Microsoft, Netflix,…

Jon C. Ogg | Aug 28, 2019 at 11:20 AM EDT

7 Giant Mergers Transforming the Face of Corporate America

Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and…

Chris Lange | Aug 27, 2019 at 9:15 AM EDT

Short Sellers Hike Their Bets in Biotech

The August 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 27, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, BorgWarner, Chipotle, Cree, Dollar General, Exelon, PDC Energy, Verizon, Zynga and More

The top analyst upgrades, downgrades and initiations for Tuesday included Amgen, BorgWarner, Chipotle Mexican Grill, Cree, Dollar General, Exelon, PDC…

Chris Lange | Aug 26, 2019 at 3:20 PM EDT

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made…

Jon C. Ogg | Aug 19, 2019 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, Aramark, Chevron, Deere, Exxon, Hecla, Occidental, Urban Outfitters, Whiting and More

The top analyst upgrades, downgrades and initiations for Monday included Amgen, Aramark, Chevron, Deere, Exxon Mobile, Hecla Mining, Occidental Petroleum,…

Chris Lange | Aug 16, 2019 at 9:05 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: Walmart, Nvidia, Amgen, Applied Materials, Alibaba, Intel, Merck and More

The top analyst upgrades, downgrades and initiations on Friday included Alibaba, Amgen, Applied Materials, Intel, Merck, Nvidia and Walmart.

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:50 AM EDT

Short Sellers Make a Move on Big Biotechs

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 31, 2019 at 10:00 AM EDT

Why Amgen Is Up Despite Falling Product Sales

Amgen shares rose early Wednesday after it released better than expected second-quarter financial results late on Tuesday.

Chris Lange | Jul 25, 2019 at 8:40 AM EDT

Major Biotechs See Rising Tide in Short Interest

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 11, 2019 at 9:50 AM EDT

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data…

Chris Lange | Jun 26, 2019 at 10:05 AM EDT

Big Biotechs Scare Off Short Sellers

The June 14 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jun 12, 2019 at 8:40 AM EDT

Big Biotechs Have Short Sellers on the Run

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data…

1 … 12 13 14 15 16 … 48

Amgen : AMGN

All Amgen Articles

Amgen’s Lung Cancer Study Needs to Take a Breather

Top Analyst Upgrades and Downgrades: Amgen, Bank of America, Box, Chico’s FAS, Microsoft, Netflix, NXP, StoneCo, Tiffany and More

7 Giant Mergers Transforming the Face of Corporate America

Short Sellers Hike Their Bets in Biotech

Top Analyst Upgrades and Downgrades: Amgen, BorgWarner, Chipotle, Cree, Dollar General, Exelon, PDC Energy, Verizon, Zynga and More

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Top Analyst Upgrades and Downgrades: Amgen, Aramark, Chevron, Deere, Exxon, Hecla, Occidental, Urban Outfitters, Whiting and More

Friday’s Top Analyst Upgrades and Downgrades: Walmart, Nvidia, Amgen, Applied Materials, Alibaba, Intel, Merck and More

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Short Sellers Make a Move on Big Biotechs

Why Amgen Is Up Despite Falling Product Sales

Major Biotechs See Rising Tide in Short Interest

Short Sellers Run for Cover From Major Biotechs

Big Biotechs Scare Off Short Sellers

Big Biotechs Have Short Sellers on the Run

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

A Caller’s Dad Turned $22,000 Into $1 Million on a Single Stock. Now the Family Faces a $150,000 Tax Decision

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

Amgen : AMGN

All Amgen Articles

Amgen’s Lung Cancer Study Needs to Take a Breather

Top Analyst Upgrades and Downgrades: Amgen, Bank of America, Box, Chico’s FAS, Microsoft, Netflix, NXP, StoneCo, Tiffany and More

7 Giant Mergers Transforming the Face of Corporate America

Short Sellers Hike Their Bets in Biotech

Top Analyst Upgrades and Downgrades: Amgen, BorgWarner, Chipotle, Cree, Dollar General, Exelon, PDC Energy, Verizon, Zynga and More

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Top Analyst Upgrades and Downgrades: Amgen, Aramark, Chevron, Deere, Exxon, Hecla, Occidental, Urban Outfitters, Whiting and More

Friday’s Top Analyst Upgrades and Downgrades: Walmart, Nvidia, Amgen, Applied Materials, Alibaba, Intel, Merck and More

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Short Sellers Make a Move on Big Biotechs

Why Amgen Is Up Despite Falling Product Sales

Major Biotechs See Rising Tide in Short Interest

Short Sellers Run for Cover From Major Biotechs

Big Biotechs Scare Off Short Sellers

Big Biotechs Have Short Sellers on the Run

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

A Caller’s Dad Turned $22,000 Into $1 Million on a Single Stock. Now the Family Faces a $150,000 Tax Decision

Featured Reads

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60